Evidence map›Paper›PMID 36757316›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2023

High occurrence of

Magdalena Nüesch-Inderbinen, Lore Heyvaert, Andrea Treier, Katrin Zurfluh, Nicole Cernela, Michael Biggel, Roger Stephan

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Microorganisms · 2025
    Article
  5. Emergence of Linezolid Resistance GenesAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Complete genome sequence of the linezolid-resistant clinicalMicrobiology resource announcements · 2024
    Article
  9. The Impact ofPathogens (Basel, Switzerland) · 2024
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Magdalena Nüesch-InderbinenInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Lore HeyvaertDepartment Veterinary and Biosciences, Faculty Veterinary Medicine, University of Ghent, Ghent, Belgium.
Andrea TreierInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Katrin ZurfluhInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Nicole CernelaInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Michael BiggelInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Roger StephanInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
University of Zurich · CHGhent University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionEnterococci harbouring genes encoding resistance to florfenicol and the oxazolidinone antimicrobial linezolid have emerged among food-producing animals and meat thereof, but few studies have analysed their occurrence in raw meat-based diets (RMBDs) for pets.AimWe aimed to examine how far RMBDs may represent a source of bacteria with oxazolidinone resistance genes.MethodsFifty-nine samples of different types of RMBDs from 10 suppliers (three based in Germany, seven in Switzerland) were screened for florfenicol-resistant Gram-positive bacteria using a selective culture medium. Isolates were phenotypically and genotypically characterised.ResultsA total of 27

Indexed as

Anti-Infective AgentsEnterococcus faeciumGram-Positive Bacterial InfectionsOxazolidinonesAnimalsAnti-Bacterial AgentsChloramphenicolDietDrug Resistance, BacterialEnterococcaceaeEnterococcus faecalisHumansLinezolidMeatMicrobial Sensitivity TestsPetsAnti-Bacterial AgentsAnti-Infective AgentsChloramphenicolflorfenicolLinezolidOxazolidinonesThiamphenicoldogs, dog owners, public healthEnterococcuslinezolid resistanceraw pet foodVagococcus

Identifiers

PMID36757316
PMCPMC9912375
OpenAlexW4319656444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.